Palvella Therapeutics's total assets for Q3 2025 were $66.94M, a decrease of -9.23% from the previous quarter. PVLA total liabilities were $28.25M for the fiscal quarter, a 8.81% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.